Full Press Release Details
Fresenius Medical Care AG & Co. KGaA
ISIN: DE0005785802 // WKN: 578580
ISIN: US3580291066 // CUSIP: 358029106
Announcement pursuant to sections 246 para.
4 sentence 1, 249 para. 1 sentence 1 German Stock Corporation Act (Aktiengesetz - AktG)
Pursuant to sections 246 para. 4 sentence 1, 249
para. 1 sentence 1 German Stock Corporation Act (Aktiengesetz - AktG), we announce that an action for contestation and annulment
(Anfechtungs- und Nichtigkeitsklage) has been filed against the resolution adopted at the Extraordinary General Meeting of Fresenius
Medical Care AG & Co. KGaA on July 14, 2023 regarding agenda item 1 (Resolution on the conversion of the Company into the legal form
of a stock corporation). Based on the motions filed by the plaintiffs, it is unclear whether the action is also directed against the resolution
of the Extraordinary General Meeting regarding agenda item 2 (Resolution on the election of the members of the supervisory board of Fresenius
Medical Care AG). The action has been filed before the Regional Court of Nuremberg-F rth (Landgericht N rnberg-F rth),
Chamber for Commercial Matters (Kammer f r Handelssachen), and is pending under file number 1 HK O 4610/23.
The court has ordered written preliminary proceedings.
Hof, this September 2023
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care Management AG
The Management Board